Webinar on-demand

Why you should consider Göttingen Minipigs as your large animal model

Watch an informative
hour about the benefits of Göttingen Minipigs in translational research

Download this event to learn more about the use of minipigs in biomedical research
  • This field is for validation purposes and should be left unchanged.

In this live webinar, we will present and discuss why you should consider Göttingen Minipigs as your large animal model

“We strongly believe that a more extensive use of Göttingen Minipigs, possessing huge anatomical, physiological, and biochemical similarities to humans will increase the translational value of the preclinical studies,” says Lars Friis Mikkelsen, CEO at Ellegaard Göttingen Minipigs.

Host and speakers

  • Host, Lars Friis Mikkelsen
  • CEO, Ellegaard Göttingen Minipigs
  • Speaker, Susanne Mohr
  • Senior Toxicology Project Lead, F. Hoffmann-La Roche, Basel, Switzerland
  • Speaker, Steven Van Cruchten
  • Professor, Comparative Perinatal Development, University of Antwerp, Belgium
  • Speaker, Edward Marsden
  • Associate Director, ERT, DART & Juvenile Toxicology, Charles River Laboratories, Lyon, France

Download webinar here

  • This field is for validation purposes and should be left unchanged.